Literature DB >> 3512714

Interleukin 1 is a radioprotector.

R Neta, S Douches, J J Oppenheim.   

Abstract

Pretreatment with recombinant interleukin 1 (IL 1) protects mice in a dose-dependent manner from lethal effects of ionizing radiation. Two thousand units of IL 1, given i.p. 20 hr before irradiation, protect 88% of C57B1/6 mice from an LD100/17 radiation dose (dose of radiation that kills 100% mice in 17 days), and 1000 U of IL 1 protect 100% of DBA/1 mice from an LD50/30 dose. This finding provides the first evidence that a cytokine, IL 1, which acts as a differentiation- and maturation-inducing agent for a variety of cells, also can serve as a signal that initiates radioprotective events in vivo. Because many of the exogenous immunomodulators that have been shown to be radioprotective also induce endogenous IL 1 production, our observation suggests that IL 1 may mediate their radioprotective effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3512714

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Radiation protective effect of an extract from Chelidonium majus.

Authors:  Jie-Young Song; Hyun-Ok Yang; Ji-Young Shim; Young-Soo Han; In-Sung Jung; Yeon-Sook Yun
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

Review 2.  Modifying radiation damage.

Authors:  Kwanghee Kim; William H McBride
Journal:  Curr Drug Targets       Date:  2010-11       Impact factor: 3.465

Review 3.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

4.  Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver.

Authors:  Claudia Orelio; Marian Peeters; Esther Haak; Karin van der Horn; Elaine Dzierzak
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

5.  Interleukin-1-mediated hematopoietic cell regulation in the aorta-gonad-mesonephros region of the mouse embryo.

Authors:  Claudia Orelio; Esther Haak; Marian Peeters; Elaine Dzierzak
Journal:  Blood       Date:  2008-09-19       Impact factor: 22.113

Review 6.  Interleukins. Clinical pharmacology and therapeutic use.

Authors:  W E Aulitzky; M Schuler; C Peschel; C Huber
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

7.  Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice.

Authors:  R A Pecyk; E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

Review 8.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

9.  Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.

Authors:  S Tanaka; S Tabuchi; K Watanabe; H Takigawa; K Akatsuka; H Numata; Y Hokama; T Hori
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

10.  Radioprotection of mice by recombinant rat stem cell factor.

Authors:  K M Zsebo; K A Smith; C A Hartley; M Greenblatt; K Cooke; W Rich; I K McNiece
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.